Freeline Therapeutics Holdings plc Quarterly Assets, Current in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Freeline Therapeutics Holdings plc quarterly Assets, Current history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Assets, Current for the quarter ending September 30, 2023 was $34M, a 54.1% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $34M -$40.1M -54.1% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $45.8M -$50.3M -52.3% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $63.9M -$58.5M -47.8% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $67.6M -$60.7M -47.3% Dec 31, 2022 6-K 2023-12-01
Q3 2022 $74.1M -$84.4M -53.3% Sep 30, 2022 6-K 2022-11-15
Q2 2022 $96.1M -$92.2M -49% Jun 30, 2022 6-K 2022-08-09
Q1 2022 $122M -$101M -45.3% Mar 31, 2022 6-K 2022-05-10
Q4 2021 $128M -$130M -50.3% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $159M Sep 30, 2021 6-K 2021-11-09
Q2 2021 $188M +$58.4M +45% Jun 30, 2021 6-K 2021-08-16
Q1 2021 $223M Mar 31, 2021 6-K 2021-05-17
Q4 2020 $258M +$169M +190% Dec 31, 2020 20-F 2022-03-31
Q2 2020 $130M Jun 30, 2020 6-K 2020-10-29
Q4 2019 $89M Dec 31, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.